Andrea Wecker
Department of Medicine
Eastern Virginia Medical School
Andrea Wecker has not added Biography.
If you are Andrea Wecker and would like to personalize this page please email our Author Liaison for assistance.
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
The Journal of clinical investigation Mar, 2003 | Pubmed ID: 12618526
Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis.
Circulation Jul, 2004 | Pubmed ID: 15210598
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.
The Journal of clinical investigation Feb, 2005 | Pubmed ID: 15690083
Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
Circulation Mar, 2005 | Pubmed ID: 15723985
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
Circulation May, 2005 | Pubmed ID: 15897348
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia.
Vascular medicine (London, England) Feb, 2005 | Pubmed ID: 15920995
Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
Circulation Jul, 2005 | Pubmed ID: 15983249
Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization.
The Journal of experimental medicine Jan, 2006 | Pubmed ID: 16401693
Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury.
Circulation research Mar, 2006 | Pubmed ID: 16484619
Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI.
Nature clinical practice. Cardiovascular medicine Mar, 2006 | Pubmed ID: 16501618
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2006 | Pubmed ID: 16835303
Derivation and characterization of bone marrow-derived multipotent stem cells.
Experimental hematology Nov, 2006 | Pubmed ID: 17046582
Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
Circulation Nov, 2006 | Pubmed ID: 17088460
Bone marrow-derived stem cell therapy in ischemic heart disease.
Regenerative medicine May, 2006 | Pubmed ID: 17465787
Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart.
The Journal of experimental medicine Dec, 2007 | Pubmed ID: 18070934
Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.
Circulation Feb, 2009 | Pubmed ID: 19171856
Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.
Circulation Mar, 2010 | Pubmed ID: 20176991
CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension.
Journal of hypertension Oct, 2013 | Pubmed ID: 23881298
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved